The phrase "ability of developing country" is not entirely correct in English; it should be "ability of a developing country." You can use it when discussing the capabilities or potential of a developing nation in various contexts, such as economics, education, or technology.
Example: "The ability of a developing country to innovate can significantly impact its growth trajectory."
Alternatives: "capability of a developing nation" or "potential of a developing country."
FAO's food safety capacity development activities support the ability of developing countries and countries in transition to participate more effectively in Codex.
These deals exploit the asymmetric nature of bargaining power between developed and developing nations, divert trade away from nations with true comparative advantages and curtail the ability of developing countries to deploy effective policies for development.
With the spread of industrialization to all areas of the globe, scientists and policymakers alike have voiced mounting concerns over the ability of developing countries to limit the public health impacts of unchecked development.
A stable, open and transparent climate could increase the ability of developing countries to attract the foreign direct investment they so desperately need.
The ability of developing countries to connect firms, suppliers and consumers to global supply chains efficiently is essential to their competitiveness, says the World Bank in a new study on trade logistics.
By drawing on a range of real-world examples, Bellin illustrates the ability of developing countries to reconfigure state-society relations, redistribute power more evenly in society, and erode the peremptory power of the authoritarian state, even where democracy is stalled.
The Obama administration's efforts to restrict the ability of developing countries to access medication goes beyond HIV treatment: The standards currently being pushed by USTR in the trade deal would apply to all drugs, including vaccines and treatments for heart disease, cancer and other life-threatening illnesses.
Some participants (e.g. Fenning, 27/11(2)), however, highlighted the potential negative impacts that IPR over biotechnological products, or the processes used to make them, might have on the ability of developing countries to do this.
